- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 24.42M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.95M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.6M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.03M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$772K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $354K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.39M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.29M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.15M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.06M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $595K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $813K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $595K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $813K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $970K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.99M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.88M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.97M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.59 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.67 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.59 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.67 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $585K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $747K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $427K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $347K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.01M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.07M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.01M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.09M |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $2K |